Introduction: The metabolic syndrome (MS) corresponds to the coexistence of several metabolic disorders including three (3) factors out of five (5) in the same individual. These five (5) major criteria are central or abdominal obesity, hypertriglyceridemia, low High-Density Lipoprotein cholesterol (HDLc), hyperglycemia, and elevated blood pressure. It has been the subject of various definitions over the past 10 years. It is a clinical-biological entity recognized by the World Health Organization (WHO) in 1998, the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) in 2001, the International Diabetes Federation (IDF) in 2005, then the IDF Harmonization Consensus in 2009. The objective of this study was to determine the prevalence of metabolic syndrome in the medico-surgical emergency department of the Donka national hospital. Methods: This was a descriptive study, data collection took place from February 5 to July 5, 2022 and, covering all patients aged 16 and over, without distinction of sex, origin received in consultation in the medical unit in the emergency department of Donka and having agreed to participate in the study. Anthropometric, clinical and biological data were recorded. Results: We recruited 107 patients whose age ranged from 20 to 94 years with a mean age of 58.92 ± 13.78 years. The prevalence of metabolic syndrome in our study population was 6.30% with a female predominance of 73.83%. The most frequent components of the metabolic syndrome were abdominal obesity (100%) followed by hyperglycemia (85.98%) and hypertension (85.05%). Among the complications related to the metabolic syndrome, diabetes was found with (46.73%), hypertension (43.93%) and stroke (16.93%). Conclusion: Our results show a significant prevalence of the metabolic syndrome and its main complications, which were diabetes, hypertension and stroke. These data justify early detection and treatment strategies.
References
[1]
Eckel, H.R. (2015) The Metabolic Syndrome. In: Longo, D.L., Kasper, D.L., Jameson, J.L., Fauci, A.S., Hauser, S.L. and Loscalzo, J., Eds. Harrison’s Principles of Internal Medicine, McGraw-Hill, New York, 2449-2454.
[2]
(2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106, 314-321. https://doi.org/10.1161/circ.106.25.3143
[3]
Alberti, K.G., Zimmet, P. and Shaw, J. (2005) The Metabolic Syndrome: A New Worldwide Definition. The Lancet, 366, 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
[4]
Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. (2009) Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the IDF Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circu-lation, 120, 1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
[5]
Eckel, R.H., Grundy, S.M. and Zimmet, P.Z. (2005) The Metabolic Syndrome. The Lancet, 364, 1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7
[6]
Cameron, A.J., Shaw, J.E. and Zimmet, P.Z. (2004) The Metabolic Syndrome: Prevalence in Worldwide Populations. Endocrinology and Metabolism Clinics of North America, 33, 351-375. https://doi.org/10.1016/j.ecl.2004.03.005
[7]
Ford, E.S., Giles, W.H. and Dietz, W.H. (2002) Prevalence of the Metabolic Syndrome among US Adults: Finding from the Third National Health and Nutrition Examination Survey. JAMA, 287, 356-359. https://doi.org/10.1001/jama.287.3.356
[8]
Balkau, B., Vernay, M., Mhamdil, L., Novak, M., Arondel, D., Vol, S., et al. (2003) The Incidence and Persistence of the NCEP (National Cholesterol Education Program) Metabolic Syndrome. The French D.E.S.I.R. Study. Diabetes & Metabolism, 29, 526-532. https://doi.org/10.1016/S1262-3636(07)70067-8
[9]
Yessoufou, A.G., Behanzin, J., Djihoumeto, E., Isstina, Z.A., Ahokpe, M. and Sezan, A. (2015) Epidemiological Aspects of the Metabolic Syndrome in the Obese Population of the Commune Ouidah in Southwestern Benin. Anthropology, 33, 111-116.
[10]
N’Guetta, R., Yao, H., Brou, I., Ekou, A., Do, P. and Angoran, I. (2016) Prevalence and Characteristics of Metabolic Syndrome in Hypertensives in Abidjan. Annals of Cardiology and Angiology, 65, 131-135. https://doi.org/10.1016/j.ancard.2016.04.009
[11]
Diallo, A.M., Diallo, M.M., Baldé, N.M., Diakité, M., Baldé, T.A., Bah, A., et al. (2012) Prevalence and Association of the Different Criteria of the Metabolic Syndrome in a Population of Type 2 Diabetics in Guinea. Medicine of Metabolic Diseases, 6, 542-545. https://doi.org/10.1016/S1957-2557(12)70482-0
[12]
Cisse, F., Mehrez, A., Thiam, S., Lamkinsi, T., Ndiaye, A., Samba, A., et al. (2020) Study of the Prevalence of the Metabolic Syndrome in an Adult Senegalese Population. African and Malagasy Review for Scientific Research/Health Sciences, 2, 1-7.
[13]
Ravikaran, M., Bhansali, A., Ravikumar, P., et al. (2010) Prevalence and Risk of Metabolic Syndrome among Asian Indians: A Community Survey. Diabetes Research and Clinical Practice, 89, 181-188. https://doi.org/10.1016/j.diabres.2010.03.010
[14]
Yu, S., Guo, X., Yang, H., Zheng, L. and Sun, Y. (2015) Metabolic Syndrome in Hypertensive Adults from Rural Northeast China: An Update. BMC Public Health, 15, Article No. 247. https://doi.org/10.1186/s12889-015-1587-7
[15]
Sarr, A., Lopez-Sall, P., Ndour-Mbaye, N.M., et al. (2012) Frequency of Plurimetabolic Syndrome and Associated Abnormalities in a Black Population in Senegal. Metabolic Disease Medicine, 6, 238-243. https://doi.org/10.1016/S1957-2557(12)70405-4
[16]
Lambert, M., Paradis, G., O’Loughlin, J., et al. (2004) Insulin Resistance Syndrome in a Representative Sample of Children and Adolescents from Quebec, Canada. International Journal of Obesity and Related Metabolic Disorders, 28, 833-841. https://doi.org/10.1038/sj.ijo.0802694
[17]
Hauhouot-Attoungbré, M.L., Yayo, E.S., Konan, J.L., Koné, F., Siara, E. and Monnet, D. (2013) Fattening Diet and Metabolic Syndrome in Ivory Coast. Annals of Clinical Biology, 71, 207-210. https://doi.org/10.1684/abc.2013.0808
[18]
Zeber, J. and Parchman, M.L. (2010) Cardiovascular Disease in Type 2 Diabetes: Attributable Risk due to Modifiable Risk Factors. Canadian Family Physician, 56, e302-e307.
